Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer
暂无分享,去创建一个
K. Nishio | T. Sudo | M. Tanioka | K. Nakagawa | K. Sakai | S. Negoro | S. Takao | H. Minami | K. Kajimoto | K. Hirokaga | T. Sakuma